RYPONTI Trademark

Trademark Overview


On Wednesday, May 27, 2015, a trademark application was filed for RYPONTI with the United States Patent and Trademark Office. The USPTO has given the RYPONTI trademark a serial number of 86641985. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 9, 2023. This trademark is owned by Glaxo Group Limited. The RYPONTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ryponti

General Information


Serial Number86641985
Word MarkRYPONTI
Filing DateWednesday, May 27, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 9, 2023
Registration Number5089121
Registration DateTuesday, November 29, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, June 9, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 29, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 29, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, September 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 6, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, August 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 4, 2016ASSIGNED TO LIE
Thursday, July 28, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, March 8, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, March 8, 2016INQUIRY TO SUSPENSION E-MAILED
Tuesday, March 8, 2016SUSPENSION INQUIRY WRITTEN
Saturday, September 5, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, September 5, 2015LETTER OF SUSPENSION E-MAILED
Saturday, September 5, 2015SUSPENSION LETTER WRITTEN
Tuesday, September 1, 2015ASSIGNED TO EXAMINER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 30, 2015NEW APPLICATION ENTERED